Trial intelligence / Profile preview

Metformin for small abdominal aortic aneurysm

ACTRN12618001707257Phase 4Recruiting

Sponsor
James Cook University
Start
Feb 2021
Modality
Small Molecules
Countries
4
01

Overview

Phase 4, randomised, single-blind trial in abdominal aortic aneurysm (AAA) comparing Metformin extended release with Placebo (2 arms). Primary endpoint: AAA-associated events. Started Feb 2021; status: recruiting.

02

Drugs

metformin
03

Conditions

abdominal aortic aneurysm (AAA)

Beyond the preview

Go deeper on ACTRN12618001707257.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12618001707257.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call